Successful Development of a Micro Missile that Strikes Only Cancer Cells

It can deliver a fatal dose of anticancer drugs only to cancer cells.

814
Naoki Yoshioka
Naoki Yoshioka

XAMOSCHi Chief Editor

Establisher of tempo, Inc. a web production company. Naoki has been in the web industry ever since he established the company in 2000. He specializes in tech, culture and also loves international movies and literature. Naoki is also keen on studying old Japanese material arts (Sousuishiryu-Kumiuchi-Koshinomawari: Seirenkan and Aikido: Aikikai) and continues his training until today.

Dr. Masaharu Seno of Okayama University and Ensuiko Sugar Refining Co., Ltd developed a missile therapy for cancer cells by directly shooting cancer cells with an anticancer drug capsule.

 

・They added sugar to the anticancer drug, Pacitaxel

・This made the Paclitaxel highly water soluble
・これをLiposome内の水に溶解させて封入
・Add Trastuzumab to the surface of Liposome
・This made it possible to bond with certain cancer cells

 

This technology made it possible to deliver the anticancer drug  only to certain cancer cells without reacting to normal cells.  According to Nikkan Kokyo Shimbun, even in the experiment where they applied a fatal dose of Paclitaxel to the mouse, the mouse survived and was able to  suppress growth of the  tumor.

 

Since this method does not function to normal cells, it would be possible to control side affects, which is the largest issue of anticancer drugs. We hope that it would soon be put into practical use.

 

 

Translated by Elena

 

SOURCE
ENSUI-KOUSEITOU

NikkanKogyoShinbun

Latest

A Japanese watch manufacture launched a “wrist computer” in 1984.

2089

The sushi bar “Kiyotomo” designed sophisticatedly by Shiro Kuramata, has been dismantled by professionals and shipped to Hong Kong.

1990

So you hate the stickiness and the smell of natto?? Well, let’s see what we can do with biotechnology...

1844

The Gear for Ultralight Hiking - Non-attachment and the Identity -

4104

Ummm… yes, there is a propeller but...

1590

Comments